汉森医疗
HNSN

from December 31, 2015 to March 31, 2016 Issuances of common stock from restricted stock units

From December 31, 2014 to December 31, 2015 Issuance of Series A convertible preferred stock,net of discount related to warrants of $14,776 and issuance cost of $546 Issuance of common stock upon conversion of Series A convertible preferred stock Issuances of common stock from restricted stock units Issuance of common stock under employee stock purchase plan Retire Treasury shares On September 22, 2015, the Company effected a reverse stock split of its common stock by a ratio of 1-for-10 (the “ Reverse Split”).

from December 31, 2014 to September 30, 2015 Issuance of Series A convertible preferred stock, net of issuance cost Conversion of Series A convertible preferred stock to common stock Issuances of common stock from restricted stock units Issuance of common stock under employee stock purchase plan Retirement of treasury shares On September 22, 2015, the Company effected a reverse stock split of its common stock by a ratio of 1-for-10 (the “ Reverse Split”).

On September 22, 2015, the Company effected a reverse stock split of its common stock by a ratio of 1-for-10 (the “ Reverse Split”).

from December 31, 2014 to June 30, 2015 Issuance of Series A convertible preferred stock, net of issuance cost Conversion of Series A convertible preferred stock to common stock Issuance of common stock under equity incentive plan Issuances of common stock from restricted stock units Issuance of common stock under employee stock purchase plan All 53,846 shares of the Series A preferred stock were converted into 55,094,915 shares of common stock on May 12, 2015.

from December 31, 2013 to December 31, 2014 Issuance of common stock under equity incentive plan Issuance of common stock under employee stock purchase plan Issuance of common stock upon exercise of Series A warrants Issuance of common stock upon Series B/C warrant exchange

from December 31, 2012 to December 31, 2013 Exercise of stock options and issuance of common stock pursuant to the employee equity incentive plan Issuance of common stock pursuant to the employee stock purchase plan Issuance of common stock pursuant to private placement Issuance of common shares in connection with the litigation settlement

from December 31, 2011 to December 31, 2012 Exercise of stock options Issuance of common stock pursuant to the employee stock purchase plan Issuance of common stock pursuant to private placement

from December 31, 2010 to December 31, 2011 Exercise of stock options Issuance of common stock pursuant to the employee stock purchase plan Issuance of common stock pursuant to private placement Issuance of common stock for technology acquired

from December 31, 2009 to December 31, 2010 Exercise of stock options Issuance of common stock pursuant to the employee stock purchase plan Issuance of common stock pursuant to public offering Issuance of common stock for services performed

from December 31, 2008 to December 31, 2009 Exercise of stock options Issuance of common stock pursuant to the employee stock purchase plan Issuance of common stock pursuant to secondary public offering

from December 31, 2007 to December 31, 2008 Exercise of stock options Issuance of common stock pursuant to the employee stock purchase plan Issuance of common stock pursuant to secondary public offering

from December 31, 2006 to December 31, 2007 Exercise of stock options Issuance of common stock pursuant to the employee stock purchase plan Net exercise of warrants to purchase common stock Issuance of common stock pursuant to acquisition of AorTx, Inc.

from December 31, 2005 to December 31, 2006 Exercise of over-allotment option by underwriters in December 2006 in connection with the IPO for cash at $12.00 per share, net of discounts, commissions and issuance costs of $787 Exercise of stock options in February through November for cash at $0.40, $0.56, $1.40, $2.40 and $7.76 per share Issuance of common stock in initial public offering (“IPO”) in November 2006 for cash at $12.00 per share, net of discounts, commissions and issuance costs of $7,210 Conversion of preferred stock to common stock in November 2006 in connection with the IPO In November 2006, the Company effected a one-for-four reverse split of its common stock and preferred stock which has been retroactively applied to these financial statements.

from December 31, 2004 to December 31, 2005 Issuance of Series B redeemable convertible preferred stock in March 2005 at $5.28 per share related to an asset purchase, net of issuance costs of $115 Issuance of Series B redeemable convertible preferred stock in April 2005 for cash at $4.20 per share Repurchase of unvested shares in May and June 2005 for cash at $0.40 per share Issuance of Series B redeemable convertible preferred stock in September 2005 at $5.84 per share related to a license agreement Issuance of Series C redeemable convertible preferred stock in November 2005 for cash at $6.16 per share, net of issuance costs of $148 Exercise of stock options in February through December 2005 for cash at $0.40 and $0.56 per share